The predictive role of platelet to lymphocyte ratio in the occurrence of anastomotic complications following gastric resections for neoplasia – single centre experience

1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin D.M, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018;144(8):1941-53. DOI: 10.1002/ijc.3193710.1002/ijc.31937Search in Google Scholar

2. deMartel C, Parsonnet J. Stomach cancer. In: MJ Thun, MS Linet, JR Cerhan, CA Haiman, D, Schottenfeld eds. Cancer epidemiology and prevention. 4th ed. New York: Oxford University Press; 2018:593-610.Search in Google Scholar

3. Freddie B, Ferlay J, Soerjomataram I, Siegel R, Torre L.A, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2018;68:394-424 DOI: 10.3322/caac.2149210.3322/caac.21492Search in Google Scholar

4. https://gco.iarc.fr/today/data/factsheets/populations/642-Romania-fact-sheets.pdfSearch in Google Scholar

5. He W, Tu J, Huo Z. Surgical interventions for gastric cancer: a review of systematic reviews. Int J Clin Exp Med. 2015;8:13657-13669.Search in Google Scholar

6. Tang HN, Hu JH. A comparison of surgical procedures and postoperative cares for minimally invasive laparoscopic gastrectomy and open gastrectomy in gastric cancer. Int J Clin Exp Med. 2015;8:10321-10329.Search in Google Scholar

7. Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumor Biol. 2017;39(7). DOI: 10.1177/101042831771462610.1177/1010428317714626Search in Google Scholar

8. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-713. DOI: 10.1158/1055-9965.EPI-13-105710.1158/1055-9965.EPI-13-1057Search in Google Scholar

9. Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014:15(11):e493-503 DOI: 10.1016/S1470-2045(14)70263-310.1016/S1470-2045(14)70263-3Search in Google Scholar

10. Roxburgh CS, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. 2014;110:1409-1412. DOI: 10.1038/bjc.2014.9010.1038/bjc.2014.90396063324548867Search in Google Scholar

11. Hirahara T, Arigami T, Yanagita S, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019;19(1):672. DOI: 10.1186/s12885-019-5903-y10.1186/s12885-019-5903-y661515131286873Search in Google Scholar

12. Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Bio-markers Prev. 2014;23:1204-1212. DOI: 10.1158/1055-9965.EPI-14-014610.1158/1055-9965.EPI-14-014624793958Search in Google Scholar

13. Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016;23:646-654. DOI: 10.1245/s10434-015-4869-510.1245/s10434-015-4869-526416715Search in Google Scholar

14. Zhao QT, Yuan Z, Zhang H, Zhang XP, Wang HE, Wang ZK, et al. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients. Int J Cancer. 2016;139:164-170. DOI: 10.1002/ijc.3006010.1002/ijc.3006026915723Search in Google Scholar

15. Lu C, Gao P, Yang Y, Chen X, Wang L, Yu D, et al. Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer. Oncotarget. 2017;8:86287-86295. DOI: 10.18632/oncotarget.2114110.18632/oncotarget.21141568968529156795Search in Google Scholar

16. Mártha O, Balan D, Porav-Hodade D, Drágus E, Vartolomei MD, Chibelean CB, et al. The role of neutro-phil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer. Rev Romana Med Lab. 2020;28(1):29-38. DOI: 10.2478/rrlm-2020-000110.2478/rrlm-2020-0001Search in Google Scholar

17. Wang F, Liu ZY, Xia YY, et al. Changes in neutrophil/ lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10(6):3411-3418. DOI: 10.3892/ol.2015.378310.3892/ol.2015.3783466571426788143Search in Google Scholar

18. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373-2380. DOI: 10.1002/ijc.2317310.1002/ijc.2317317893866Search in Google Scholar

19. Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. DOI: 10.1186/1471-2407-13-35010.1186/1471-2407-13-350372981423876227Search in Google Scholar

20. Nakamura N, Kinami S, Fujii Y, et al. The neutrophil/ lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis. World J Surg Oncol. 2019;17(1):108. DOI: 10.1186/s12957-019-1651-310.1186/s12957-019-1651-3659351231238937Search in Google Scholar

21. Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, et al. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015;113:150-158. DOI: 10.1038/bjc.2015.18310.1038/bjc.2015.183464754626022929Search in Google Scholar

22. Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2017;265:539-546. DOI: 10.1097/.0000000000001743Search in Google Scholar

23. Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, et al. Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in Resectable pancreatic Cancer. Ann Surg Oncol. 2017;24:808-815. DOI: 10.1245/s10434-016-5634-010.1245/s10434-016-5634-0530607027770341Search in Google Scholar

24. Heras P, Hatzopoulos A, Kritikos N, Kritikos K. Platelet count and tumor progression in gastric cancer patients. Scand J Gastroenterol. 2010;45:1005-1006. DOI: 10.3109/0036552100379722110.3109/0036552100379722120377467Search in Google Scholar

25. Dobru D, Boeriu A, Mocan S, Pascarenco O, Boeriu C, Molnar C. Gastric carcinoid and therapeutic options, Case report and review of the literature. J Gastrointestin Liver Dis. 2013;22(1):93-6.Search in Google Scholar

26. Seretis C, Seretis F, Lagoudianakis E, Politou M, Gemenetzis G, Salemis NS. Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: a pilot study in breast cancer patients. Int J Surg Oncol. 2012;2012:653608. DOI: 10.1155/2012/65360810.1155/2012/653608353286923304480Search in Google Scholar

27. Mertoglu C, Gunay M, Gurel A, Gungor M, Gul V. Ischemic modified albumin increases in acute kidney injury. Rev Romana Med Lab. 2018;26(1):37-43. DOI: 10.2478/rrlm-2018-000210.2478/rrlm-2018-0002Search in Google Scholar